Breast cancer prognostic classification in the molecular era: The role of histological grade

Emad A. Rakha, Jorge S. Reis-Filho, Frederick Baehner, David J. Dabbs, Thomas Decker, Vincenzo Eusebi, Stephen B. Fox, Shu Ichihara, Jocelyne Jacquemier, Sunil R. Lakhani, José Palacios, Andrea L. Richardson, Stuart J. Schnitt, Fernando C. Schmitt, Puay Hoon Tan, Gary M. Tse, Sunil Badve, Ian O. Ellis

Research output: Contribution to journalArticle

332 Citations (Scopus)

Abstract

Breast cancer is a heterogeneous disease with varied morphological appearances, molecular features, behavior, and response to therapy. Current routine clinical management of breast cancer relies on the availability of robust clinical and pathological prognostic and predictive factors to support clinical and patient decision making in which potentially suitable treatment options are increasingly available. One of the best-established prognostic factors in breast cancer is histological grade, which represents the morphological assessment of tumor biological characteristics and has been shown to be able to generate important information related to the clinical behavior of breast cancers. Genome-wide microarray-based expression profiling studies have unraveled several characteristics of breast cancer biology and have provided further evidence that the biological features captured by histological grade are important in determining tumor behavior. Also, expression profiling studies have generated clinically useful data that have significantly improved our understanding of the biology of breast cancer, and these studies are undergoing evaluation as improved prognostic and predictive tools in clinical practice. Clinical acceptance of these molecular assays will require them to be more than expensive surrogates of established traditional factors such as histological grade. It is essential that they provide additional prognostic or predictive information above and beyond that offered by current parameters. Here, we present an analysis of the validity of histological grade as a prognostic factor and a consensus view on the significance of histological grade and its role in breast cancer classification and staging systems in this era of emerging clinical use of molecular classifiers.

Original languageEnglish
Article number207
JournalBreast Cancer Research
Volume12
Issue number4
DOIs
StatePublished - Aug 24 2010

Fingerprint

Breast Neoplasms
Neoplasm Staging
Neoplasms
Genome
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Rakha, E. A., Reis-Filho, J. S., Baehner, F., Dabbs, D. J., Decker, T., Eusebi, V., ... Ellis, I. O. (2010). Breast cancer prognostic classification in the molecular era: The role of histological grade. Breast Cancer Research, 12(4), [207]. https://doi.org/10.1186/bcr2607

Breast cancer prognostic classification in the molecular era : The role of histological grade. / Rakha, Emad A.; Reis-Filho, Jorge S.; Baehner, Frederick; Dabbs, David J.; Decker, Thomas; Eusebi, Vincenzo; Fox, Stephen B.; Ichihara, Shu; Jacquemier, Jocelyne; Lakhani, Sunil R.; Palacios, José; Richardson, Andrea L.; Schnitt, Stuart J.; Schmitt, Fernando C.; Tan, Puay Hoon; Tse, Gary M.; Badve, Sunil; Ellis, Ian O.

In: Breast Cancer Research, Vol. 12, No. 4, 207, 24.08.2010.

Research output: Contribution to journalArticle

Rakha, EA, Reis-Filho, JS, Baehner, F, Dabbs, DJ, Decker, T, Eusebi, V, Fox, SB, Ichihara, S, Jacquemier, J, Lakhani, SR, Palacios, J, Richardson, AL, Schnitt, SJ, Schmitt, FC, Tan, PH, Tse, GM, Badve, S & Ellis, IO 2010, 'Breast cancer prognostic classification in the molecular era: The role of histological grade', Breast Cancer Research, vol. 12, no. 4, 207. https://doi.org/10.1186/bcr2607
Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V et al. Breast cancer prognostic classification in the molecular era: The role of histological grade. Breast Cancer Research. 2010 Aug 24;12(4). 207. https://doi.org/10.1186/bcr2607
Rakha, Emad A. ; Reis-Filho, Jorge S. ; Baehner, Frederick ; Dabbs, David J. ; Decker, Thomas ; Eusebi, Vincenzo ; Fox, Stephen B. ; Ichihara, Shu ; Jacquemier, Jocelyne ; Lakhani, Sunil R. ; Palacios, José ; Richardson, Andrea L. ; Schnitt, Stuart J. ; Schmitt, Fernando C. ; Tan, Puay Hoon ; Tse, Gary M. ; Badve, Sunil ; Ellis, Ian O. / Breast cancer prognostic classification in the molecular era : The role of histological grade. In: Breast Cancer Research. 2010 ; Vol. 12, No. 4.
@article{3a353c06bb624e3192e1445d803baf83,
title = "Breast cancer prognostic classification in the molecular era: The role of histological grade",
abstract = "Breast cancer is a heterogeneous disease with varied morphological appearances, molecular features, behavior, and response to therapy. Current routine clinical management of breast cancer relies on the availability of robust clinical and pathological prognostic and predictive factors to support clinical and patient decision making in which potentially suitable treatment options are increasingly available. One of the best-established prognostic factors in breast cancer is histological grade, which represents the morphological assessment of tumor biological characteristics and has been shown to be able to generate important information related to the clinical behavior of breast cancers. Genome-wide microarray-based expression profiling studies have unraveled several characteristics of breast cancer biology and have provided further evidence that the biological features captured by histological grade are important in determining tumor behavior. Also, expression profiling studies have generated clinically useful data that have significantly improved our understanding of the biology of breast cancer, and these studies are undergoing evaluation as improved prognostic and predictive tools in clinical practice. Clinical acceptance of these molecular assays will require them to be more than expensive surrogates of established traditional factors such as histological grade. It is essential that they provide additional prognostic or predictive information above and beyond that offered by current parameters. Here, we present an analysis of the validity of histological grade as a prognostic factor and a consensus view on the significance of histological grade and its role in breast cancer classification and staging systems in this era of emerging clinical use of molecular classifiers.",
author = "Rakha, {Emad A.} and Reis-Filho, {Jorge S.} and Frederick Baehner and Dabbs, {David J.} and Thomas Decker and Vincenzo Eusebi and Fox, {Stephen B.} and Shu Ichihara and Jocelyne Jacquemier and Lakhani, {Sunil R.} and Jos{\'e} Palacios and Richardson, {Andrea L.} and Schnitt, {Stuart J.} and Schmitt, {Fernando C.} and Tan, {Puay Hoon} and Tse, {Gary M.} and Sunil Badve and Ellis, {Ian O.}",
year = "2010",
month = "8",
day = "24",
doi = "10.1186/bcr2607",
language = "English",
volume = "12",
journal = "Breast Cancer Research",
issn = "1465-5411",
publisher = "BioMed Central",
number = "4",

}

TY - JOUR

T1 - Breast cancer prognostic classification in the molecular era

T2 - The role of histological grade

AU - Rakha, Emad A.

AU - Reis-Filho, Jorge S.

AU - Baehner, Frederick

AU - Dabbs, David J.

AU - Decker, Thomas

AU - Eusebi, Vincenzo

AU - Fox, Stephen B.

AU - Ichihara, Shu

AU - Jacquemier, Jocelyne

AU - Lakhani, Sunil R.

AU - Palacios, José

AU - Richardson, Andrea L.

AU - Schnitt, Stuart J.

AU - Schmitt, Fernando C.

AU - Tan, Puay Hoon

AU - Tse, Gary M.

AU - Badve, Sunil

AU - Ellis, Ian O.

PY - 2010/8/24

Y1 - 2010/8/24

N2 - Breast cancer is a heterogeneous disease with varied morphological appearances, molecular features, behavior, and response to therapy. Current routine clinical management of breast cancer relies on the availability of robust clinical and pathological prognostic and predictive factors to support clinical and patient decision making in which potentially suitable treatment options are increasingly available. One of the best-established prognostic factors in breast cancer is histological grade, which represents the morphological assessment of tumor biological characteristics and has been shown to be able to generate important information related to the clinical behavior of breast cancers. Genome-wide microarray-based expression profiling studies have unraveled several characteristics of breast cancer biology and have provided further evidence that the biological features captured by histological grade are important in determining tumor behavior. Also, expression profiling studies have generated clinically useful data that have significantly improved our understanding of the biology of breast cancer, and these studies are undergoing evaluation as improved prognostic and predictive tools in clinical practice. Clinical acceptance of these molecular assays will require them to be more than expensive surrogates of established traditional factors such as histological grade. It is essential that they provide additional prognostic or predictive information above and beyond that offered by current parameters. Here, we present an analysis of the validity of histological grade as a prognostic factor and a consensus view on the significance of histological grade and its role in breast cancer classification and staging systems in this era of emerging clinical use of molecular classifiers.

AB - Breast cancer is a heterogeneous disease with varied morphological appearances, molecular features, behavior, and response to therapy. Current routine clinical management of breast cancer relies on the availability of robust clinical and pathological prognostic and predictive factors to support clinical and patient decision making in which potentially suitable treatment options are increasingly available. One of the best-established prognostic factors in breast cancer is histological grade, which represents the morphological assessment of tumor biological characteristics and has been shown to be able to generate important information related to the clinical behavior of breast cancers. Genome-wide microarray-based expression profiling studies have unraveled several characteristics of breast cancer biology and have provided further evidence that the biological features captured by histological grade are important in determining tumor behavior. Also, expression profiling studies have generated clinically useful data that have significantly improved our understanding of the biology of breast cancer, and these studies are undergoing evaluation as improved prognostic and predictive tools in clinical practice. Clinical acceptance of these molecular assays will require them to be more than expensive surrogates of established traditional factors such as histological grade. It is essential that they provide additional prognostic or predictive information above and beyond that offered by current parameters. Here, we present an analysis of the validity of histological grade as a prognostic factor and a consensus view on the significance of histological grade and its role in breast cancer classification and staging systems in this era of emerging clinical use of molecular classifiers.

UR - http://www.scopus.com/inward/record.url?scp=78649992702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649992702&partnerID=8YFLogxK

U2 - 10.1186/bcr2607

DO - 10.1186/bcr2607

M3 - Article

C2 - 20804570

AN - SCOPUS:78649992702

VL - 12

JO - Breast Cancer Research

JF - Breast Cancer Research

SN - 1465-5411

IS - 4

M1 - 207

ER -